LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

Search

Sotera Health Co

Ouvert

SecteurSoins de santé

17.1 0.77

Résumé

Variation du prix de l'action

24h

Actuel

Min

17.01

Max

17.19

Chiffres clés

By Trading Economics

Revenu

40M

48M

Ventes

17M

311M

P/E

Moyenne du Secteur

87.05

121.746

Marge bénéficiaire

15.547

Employés

3,000

EBITDA

43M

138M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+27.8% upside

Dividendes

By Dow Jones

Prochains Résultats

26 févr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

228M

4.9B

Ouverture précédente

16.33

Clôture précédente

17.1

Sentiment de l'Actualité

By Acuity

34%

66%

61 / 351 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Neutral Evidence

Sotera Health Co Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

15 févr. 2026, 23:21 UTC

Acquisitions, Fusions, Rachats

Qube Agrees to Takeover by MAM-Led Consortium Valuing Its Equity at $6.51 Billion

15 févr. 2026, 23:45 UTC

Market Talk

Nikkei May Rise as Fears About AI Disruption Recede -- Market Talk

15 févr. 2026, 23:40 UTC

Market Talk

Gold Falls on Possible Position Adjustments -- Market Talk

15 févr. 2026, 23:06 UTC

Résultats

Thai Beverage: Spirits, Beer Businesses Posted Satisfactory EBITDA Growth, Alongside Profit Margin Expansion>Y92.SG

15 févr. 2026, 23:04 UTC

Résultats

Thai Beverage 1Q Beer Business EBITDA THB4.64B, Up 4.7% on Year>Y92.SG

15 févr. 2026, 23:04 UTC

Résultats

Thai Beverage 1Q Spirits Business EBITDA THB8.50B, Up 6.9% on Year >Y92.SG

15 févr. 2026, 23:01 UTC

Résultats

Thai Beverage 1Q EBITDA THB16.75B, Up 1.8% on Year >Y92.SG

15 févr. 2026, 23:01 UTC

Résultats

Thai Beverage 1Q FY Sales Revenue THB86.70B, Down 6.0% on Year>Y92.SG

15 févr. 2026, 22:53 UTC

Acquisitions, Fusions, Rachats

Qube: MAM-Led Offer Implies A$11.7 Billion Enterprise Value

15 févr. 2026, 22:53 UTC

Acquisitions, Fusions, Rachats

Qube: UniSuper to Transfer 15.07% Stake to Equivalent Ownership of Consortium Holding Structure

15 févr. 2026, 22:52 UTC

Acquisitions, Fusions, Rachats

Qube Shareholders to Receive A$5.20/Share in Cash

15 févr. 2026, 22:52 UTC

Acquisitions, Fusions, Rachats

Qube Holdings Agrees to Takeover by Macquarie Asset Management-Led Consortium

15 févr. 2026, 22:22 UTC

Acquisitions, Fusions, Rachats

BlueScope CEO Tania Archibald Speaking on a Call With Media

15 févr. 2026, 22:17 UTC

Acquisitions, Fusions, Rachats

BlueScope CEO: Stresses Whyalla Project Would Have to Make Sense to Shareholders

15 févr. 2026, 22:16 UTC

Acquisitions, Fusions, Rachats

BlueScope CEO: Some Job Cuts Inevitable to Ensure Company is Competitive

15 févr. 2026, 22:14 UTC

Acquisitions, Fusions, Rachats

BlueScope CEO: Higher Returns Tied to End of Capital Investment Program

15 févr. 2026, 22:14 UTC

Acquisitions, Fusions, Rachats

BlueScope Steel CEO: Higher Returns After Rebuffed Takeover Bid a 'Natural Coincidence'

15 févr. 2026, 20:48 UTC

Résultats

BlueScope: Will Now Target Net Debt of Up to A$1.5 Billion; Will Surpass as Needed

15 févr. 2026, 20:47 UTC

Résultats

BlueScope: Expects Full Benefits of Further A$150M Cost Savings in FY 2027

15 févr. 2026, 20:46 UTC

Résultats

BlueScope: Recorded Net Annualized Cost Improvements of A$190 Million in 1H

15 févr. 2026, 20:45 UTC

Résultats

BlueScope Expects a One-Third Lower 2H Result From Asia Business Vs 1H

15 févr. 2026, 20:44 UTC

Résultats

BlueScope Expects 15% Higher 2H Result From North America Business Vs 1H

15 févr. 2026, 20:44 UTC

Résultats

BlueScope Expects Lower 2H Result From Australia Business Vs 1H

15 févr. 2026, 20:43 UTC

Résultats

BlueScope Expects 2H Underlying Ebit of A$620 Million-A$700 Million

15 févr. 2026, 20:42 UTC

Résultats

BlueScope Net Debt A$2.2 Million at Dec. 31

15 févr. 2026, 20:42 UTC

Résultats

BlueScope 1H Underlying Ebit A$557.5 Million, Up 81% On-Year

15 févr. 2026, 20:41 UTC

Résultats

BlueScope 1H Underlying Ebitda A$915.3 Million, Up 39% On-Year

15 févr. 2026, 20:40 UTC

Résultats

BlueScope 1H Underlying Profit A$382.0 Million Vs A$176.4 Million Year Prior

15 févr. 2026, 20:40 UTC

Résultats

BlueScope 1H Sales Revenue From Continuing Ops A$8.22 Billion, Up 4% On-Year

15 févr. 2026, 20:39 UTC

Résultats

BlueScope Intends to Spend A$310 Million on Buyback, Or Other Returns if Share Repurchases Limited

Comparaison

Variation de prix

Sotera Health Co prévision

Objectif de Prix

By TipRanks

27.8% hausse

Prévisions sur 12 Mois

Moyen 21.88 USD  27.8%

Haut 24 USD

Bas 19.5 USD

Basé sur 6 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

6 ratings

6

Achat

0

Maintien

0

Vente

Score Technique

By Trading Central

11.3 / 13.24Support & Résistance

Court Terme

Neutral Evidence

Moyen Terme

Strong Bullish Evidence

Long Terme

Bearish Evidence

Sentiment

By Acuity

61 / 351Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Moyen

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Sotera Health Co

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems. The company also provides microbiological and analytical chemistry testing, as well as technical assistance, regulatory consulting, and advisory services. It serves medical devices, pharmaceuticals, food safety, agricultural products, cancer treatment, and high-performance materials industries, as well as commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.
help-icon Live chat